Literature DB >> 2738947

Antibacterial activity of norfloxacin against bacterial isolates from the urinary tract.

S M Qadri, S Johnson.   

Abstract

Two hundred fourteen isolates from clinical specimens were tested in vitro to determine their susceptibility pattern against norfloxacin. Of the 151 strains of gram-negative bacteria tested, 149 (98.7%) were susceptible. Sixty-three (100%) of the gram-positive bacteria tested were also susceptible to norfloxacin. Norfloxacin showed excellent activity against all bacteria isolated from urine.

Entities:  

Mesh：

Substances：

Year:  1989        PMID： 2738947      PMCID： PMC2625981     

Source DB:  PubMed          Journal:  J Natl Med Assoc        ISSN： 0027-9684            Impact factor:   1.798


  17 in total

1.  Norfloxacin and the antibacterial gamma pyridone beta carboxylic acids.

Authors:  S W Newsom; J Matthews; M Amphlett; R E Warren
Journal:  J Antimicrob Chemother       Date:  1982-07       Impact factor: 5.790

2.  Antibacterial activities of ciprofloxacin, norfloxacin, oxolinic acid, cinoxacin, and nalidixic acid.

Authors:  A L Barry; R N Jones; C Thornsberry; L W Ayers; E H Gerlach; H M Sommers
Journal:  Antimicrob Agents Chemother       Date:  1984-05       Impact factor: 5.191

3.  The antimicrobial spectrum of norfloxacin.

Authors:  S W Newsom
Journal:  J Antimicrob Chemother       Date:  1984-05       Impact factor: 5.790

4.  Comparative in vitro activity of norfloxacin against urinary tract pathogens.

Authors:  D Haase; B Urias; G Harding; A Ronald
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

5.  Norfloxacin disposition after sequentially increasing oral doses.

Authors:  B N Swanson; V K Boppana; P H Vlasses; H H Rotmensch; R K Ferguson
Journal:  Antimicrob Agents Chemother       Date:  1983-02       Impact factor: 5.191

6.  In vitro antibacterial activity of norfloxacin compared with eight other antimicrobial agents.

Authors:  B A Body; R A Fromtling; S Shadomy; H J Shadomy
Journal:  Eur J Clin Microbiol       Date:  1983-06       Impact factor: 3.267

7.  In vitro antibacterial activity of norfloxacin (MK-0366).

Authors:  A King; C Warren; K Shannon; I Phillips
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

8.  In vitro activity of MK-0366 against clinical urinary pathogens including gentamicin-resistant Pseudomonas aeruginosa.

Authors:  J Downs; V T Andriole; J L Ryan
Journal:  Antimicrob Agents Chemother       Date:  1982-04       Impact factor: 5.191

9.  Antibacterial activity of norfloxacin.

Authors:  S R Norrby; M Jonsson
Journal:  Antimicrob Agents Chemother       Date:  1983-01       Impact factor: 5.191

10.  In vitro activity of norfloxacin, a quinolinecarboxylic acid, compared with that of beta-lactams, aminoglycosides, and trimethoprim.

Authors:  H C Neu; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1982-07       Impact factor: 5.191
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.